COMPANY
Sinopep-Allsino Biopharmaceutical Co., Ltd.
Sinopep-Allsino Biopharmaceutical Co., Ltd.: bulk ingredient labeler for Cetrorelix, Lanreotide, Liraglutide, Octreotide, Retatrutide, Semaglutide, Tirzepatide, as stated by public registers.
Also written as: Sinopep-Allsino Biopharmaceutical Co.,Ltd..
BULK INGREDIENT LABELER
Lists the bulk active ingredient with FDA (NDC directory).
| Cetrorelix | Cetrorelix Acetate, BULK INGREDIENT Regulator openFDA |
|---|---|
| Lanreotide | Lanreotide Acetate, BULK INGREDIENT Regulator openFDA |
| Liraglutide | Liraglutide, BULK INGREDIENT Regulator openFDA |
| Liraglutide | LIRAGLUTIDE, BULK INGREDIENT Regulator openFDA |
| Liraglutide | Liraglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Octreotide | octreotide acetate, BULK INGREDIENT Regulator openFDA |
| Retatrutide | Retatrutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Semaglutide | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Semaglutide | Semaglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Tirzepatide | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| Tirzepatide | Tirzepatide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.